Submitted by Anonymous (not verified) on 12 April 2024 - 11:02
Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Date of authorisation: 12/12/2022, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Date of authorisation: 12/12/2022, Revision: 4, Status: Authorised